These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 19723253)
1. More regulation of industry-supported biomedical research: are we asking the right questions? Fry-Revere S; Malmstrom DB J Law Med Ethics; 2009; 37(3):420-30, 395. PubMed ID: 19723253 [TBL] [Abstract][Full Text] [Related]
2. [For and against: does sponsoring impede the growth of knowledge in medicine?]. Finzen A; Fritze J Psychiatr Prax; 2007 May; 34(4):162-4. PubMed ID: 17520527 [No Abstract] [Full Text] [Related]
3. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review. Tereskerz PM Account Res; 2003; 10(3):137-58. PubMed ID: 14979317 [No Abstract] [Full Text] [Related]
4. Managing Conflicts of Interest in Industry-Sponsored Clinical Research: More Physician Engagement Is Required. Waldstreicher J; Johns ME JAMA; 2017 May; 317(17):1751-1752. PubMed ID: 28464168 [No Abstract] [Full Text] [Related]
5. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward. Samson K Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337 [No Abstract] [Full Text] [Related]
6. Is industry money the root of all conflicts of interest in biomedical research? Caplan AL Ann Emerg Med; 2012 Feb; 59(2):87-8. PubMed ID: 21459479 [No Abstract] [Full Text] [Related]
7. Institutional policy on financial conflict of interest: objectivity in research. Shalev M Lab Anim (NY); 2003 Apr; 32(4):16-7. PubMed ID: 19753745 [No Abstract] [Full Text] [Related]
8. Better regulation of industry-sponsored clinical trials is long overdue. Wynia M; Boren D J Law Med Ethics; 2009; 37(3):410-9, 395. PubMed ID: 19723252 [TBL] [Abstract][Full Text] [Related]
10. Clinical research and industrial sponsoring: avenues towards transparency and credibility. Hildebrandt M; Ludwig WD Onkologie; 2003 Dec; 26(6):529-34. PubMed ID: 14709925 [TBL] [Abstract][Full Text] [Related]
11. Conflict of interest in industry-sponsored drug development. Emanuel EJ Clin Adv Hematol Oncol; 2007 Apr; 5(4):265-7. PubMed ID: 17607285 [No Abstract] [Full Text] [Related]
12. Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research. Tereskerz PM; Moreno J Account Res; 2005; 12(2):139-55. PubMed ID: 16220626 [TBL] [Abstract][Full Text] [Related]
14. Regulation of clinical research sponsored by pharmaceutical companies: a proposal. Sotelo J PLoS Med; 2006 Jul; 3(7):e306. PubMed ID: 16805651 [TBL] [Abstract][Full Text] [Related]
15. Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme. Jordan KA Wash Lee Law Rev; 2003; 60(1):15-109. PubMed ID: 16273696 [No Abstract] [Full Text] [Related]
17. Conflicts of interest in research involving human beings. Greco D; Diniz NM J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007 [TBL] [Abstract][Full Text] [Related]
18. Innovation incentives or corrupt conflicts of interest? Moving beyond Jekyll and Hyde in regulating biomedical academic-industry relationships. Taylor PL Yale J Health Policy Law Ethics; 2013; 13(1):135-97. PubMed ID: 23815042 [TBL] [Abstract][Full Text] [Related]
19. How skeptical should we be about industry-sponsored studies? Meador KJ Neurology; 2007 Apr; 68(15):1238; author reply 1238. PubMed ID: 17420417 [No Abstract] [Full Text] [Related]
20. [Debate on clinical research without distortion of proportions]. Verland K Ugeskr Laeger; 2005 Apr; 167(14):1489. PubMed ID: 15887739 [No Abstract] [Full Text] [Related] [Next] [New Search]